Summit Performance Associates, Inc. – Trademark Portfolio
Entity Type: 03
Summit Performance Associates, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include C.E.O. TRIBE. The owner is based in Atlanta, GA.
92 West Paces Ferry Road NW, Unit 8027
Atlanta, GA 30305
Showing of trademarks Trademarks
Trademark Classifications
Summit Performance Associates, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Summit Performance Associates, Inc. have?
Summit Performance Associates, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does Summit Performance Associates, Inc. file in?
Summit Performance Associates, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What are Summit Performance Associates, Inc.'s most well-known trademarks?
Summit Performance Associates, Inc.'s registered trademark portfolio includes well-known marks such as C.E.O. TRIBE. These are among 1 currently registered trademark in the portfolio.
What is Summit Performance Associates, Inc.'s trademark registration success rate?
Summit Performance Associates, Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.